Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6800
+0.0100 (0.60%)
NASDAQ· Last Trade: Jun 17th, 6:44 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors